Crossref
journal-article
Springer Science and Business Media LLC
Nature Cell Biology (297)
References
33
Referenced
271
-
Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 (1997).
(
10.1016/S0092-8674(00)81871-1
) / Cell by AJ Levine (1997) -
Lin, J., Chen, J., Elenbaas, B. & Levine, A. J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5E1B 55-kD protein. Genes Dev. 8, 1235–1246 (1994).
(
10.1101/gad.8.10.1235
) / Genes Dev. by J Lin (1994) -
Honda, R., Tanaka, H. & Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase for tumor suppressor p53. FEBS Lett. 420, 25– 27 (1997).
(
10.1016/S0014-5793(97)01480-4
) / FEBS Lett. by R Honda (1997) -
Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T. & Levine, A. J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554–564 (1998).
(
10.1093/emboj/17.2.554
) / EMBO J. by J Roth (1998) -
Tao, W. & Levine, A. J. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl Acad. Sci. USA 96, 3077– 3080 (1999).
(
10.1073/pnas.96.6.3077
) / Proc. Natl Acad. Sci. USA by W Tao (1999) -
Fornerod, M., Ohno, M., Yoshida, M. & Mattaj, I. W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051–1060 (1997).
(
10.1016/S0092-8674(00)80371-2
) / Cell by M Fornerod (1997) -
Fukuda, M. et al. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390, 308– 311 (1997).
(
10.1038/36894
) / Nature by M Fukuda (1997) -
Ossareh-Nazari, B., Bachelerie, F. & Dargemont, C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278, 141– 144 (1997).
(
10.1126/science.278.5335.141
) / Science by B Ossareh-Nazari (1997) -
Freedman, D. A. & Levine, A. J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell Biol. 18, 7288– 7293 (1998).
(
10.1128/MCB.18.12.7288
) / Mol. Cell Biol. by DA Freedman (1998) -
Middeler, G. et al. The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene 14, 1407–1417 ( 1997).
(
10.1038/sj.onc.1200949
) / Oncogene by G Middeler (1997) -
Stommel, J. M. et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking . EMBO J. 18, 1660–1672 (1999).
(
10.1093/emboj/18.6.1660
) / EMBO J. by JM Stommel (1999) -
Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296 –299 (1997).
(
10.1038/387296a0
) / Nature by Y Haupt (1997) -
Kubbutat, M. H., Ludwig, R. L., Ashcroft, M. & Vousden, K. H. Regulation of Mdm2-directed degradation by the C terminus of p53. Mol. Cell Biol. 18, 5690–5698 (1998).
(
10.1128/MCB.18.10.5690
) / Mol. Cell Biol. by MH Kubbutat (1998) - Marston, N. J., Jenkins, J. R. & Vousden, K. H. Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6. Oncogene 10, 1709–1715 (1995). / Oncogene by NJ Marston (1995)
-
Elenbaas, B., Dobbelstein, M., Roth, J., Shenk, T. & Levine, A. J. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain. Mol. Med. 2, 439–451 (1996).
(
10.1007/BF03401903
) / Mol. Med. by B Elenbaas (1996) -
Tanimura, S. et al. MDM2 Interacts with MDMX through their RING finger domains . FEBS Lett. 447, 5–9 (1999).
(
10.1016/S0014-5793(99)00254-9
) / FEBS Lett. by S Tanimura (1999) -
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H. & Weissman, A. M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275, 8945–8951 (2000).
(
10.1074/jbc.275.12.8945
) / J. Biol. Chem. by S Fang (2000) - Waldman, T., Kinzler, K. W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187– 5190 (1995). / Cancer Res. by T Waldman (1995)
-
Chowdary, D. R., Dermody, J. J., Jha, K. K. & Ozer, H. L. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway . Mol. Cell Biol. 14, 1997– 2003 (1994).
(
10.1128/MCB.14.3.1997
) / Mol. Cell Biol. by DR Chowdary (1994) -
Marechal, V., Elenbaas, B., Piette, J., Nicolas, J. C. & Levine, A. J. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell Biol. 14, 7414–7420 (1994).
(
10.1128/MCB.14.11.7414
) / Mol. Cell Biol. by V Marechal (1994) -
Moy, T. & Silver, P. A. Nuclear export of the small ribosomal subunit requires the Ran-GTPase cycle and certain nucleoporins. Genes Dev. 13, 2118–2133 (1999).
(
10.1101/gad.13.16.2118
) / Genes Dev. by T Moy (1999) -
Brooks, P. et al. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J. 346, 155–161 (2000).
(
10.1042/bj3460155
) / Biochem. J. by P Brooks (2000) -
Kamura, T. et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284, 657– 661 (1999).
(
10.1126/science.284.5414.657
) / Science by T Kamura (1999) -
Skowyra, D. et al. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFgrr and Rbx1. Science 284, 662–665 (1999).
(
10.1126/science.284.5414.662
) / Science by D Skowyra (1999) -
Zaika, A., Marchenko, N. & Moll, U. M. Cytoplasmically ‘sequestered’ wild type p53 protein is resistant to Mdm2-mediated degradation. J. Biol. Chem. 274, 27474–27480 ( 1999).
(
10.1074/jbc.274.39.27474
) / J. Biol. Chem. by A Zaika (1999) -
Terrell, J., Shih, S., Dunn, R. & Hicke, L. A function for monoubiquitination in the internalization of a G protein-coupled receptor. Mol. Cell 1, 193–202 ( 1998).
(
10.1016/S1097-2765(00)80020-9
) / Mol. Cell by J Terrell (1998) -
Hicke, L. Ubiquitin-dependent internalization and down-regulation of plasma membrane proteins. FASEB J. 11, 1215– 1226 (1997).
(
10.1096/fasebj.11.14.9409540
) / FASEB J. by L Hicke (1997) -
Gostissa, M. et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18, 6462– 6471 (1999).
(
10.1093/emboj/18.22.6462
) / EMBO J. by M Gostissa (1999) -
Rodriguez, M. S. et al. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18, 6455– 6461 (1999).
(
10.1093/emboj/18.22.6455
) / EMBO J. by MS Rodriguez (1999) -
Lohrum, M. A. E., Ashcroft, M., Kubbutat, M. H. G. & Vousden, K. H. Identification of a cryptic nucleolar-localization signal in MDM2. Nature Cell Biol. 2, 179–181 (2000).
(
10.1038/35004057
) / Nature Cell Biol. by MAE Lohrum (2000) -
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1, 20– 26 (1999).
(
10.1038/8991
) / Nature Cell Biol. by JD Weber (1999) -
Zhang, Y. & Xiong, Y. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3, 579– 591 (1999).
(
10.1016/S1097-2765(00)80351-2
) / Mol. Cell by Y Zhang (1999) -
Honda, R. & Yasuda, H. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18, 22–27 ( 1999).
(
10.1093/emboj/18.1.22
) / EMBO J. by R Honda (1999)
Dates
Type | When |
---|---|
Created | 23 years ago (July 26, 2002, 4:47 a.m.) |
Deposited | 2 years, 3 months ago (May 18, 2023, 3:18 p.m.) |
Indexed | 1 month, 1 week ago (July 14, 2025, 11:21 p.m.) |
Issued | 25 years ago (Aug. 9, 2000) |
Published | 25 years ago (Aug. 9, 2000) |
Published Online | 25 years ago (Aug. 9, 2000) |
Published Print | 24 years, 11 months ago (Sept. 1, 2000) |
@article{Boyd_2000, title={An intact HDM2 RING-finger domain is required for nuclear exclusion of p53}, volume={2}, ISSN={1476-4679}, url={http://dx.doi.org/10.1038/35023500}, DOI={10.1038/35023500}, number={9}, journal={Nature Cell Biology}, publisher={Springer Science and Business Media LLC}, author={Boyd, Scott D. and Tsai, Kenneth Y. and Jacks, Tyler}, year={2000}, month=aug, pages={563–568} }